Safety and Efficacy of an Early Rehabilitation Program in Surgical Intensive Care Unit (ERP)

February 14, 2017 updated by: Suk-Kyung, Asan Medical Center

Safety and Efficacy of an Early Rehabilitation Program in Surgical Intensive Care Unit (SICU)

The purpose of this study is to determine whether an early rehabilitation program in surgical intensive care unit is safe and effective in preventing critical care illness and intensive care unit acquired weakness.

Study Overview

Status

Completed

Detailed Description

Due to the complications like intensive care unit-acquired weakness, critical illness polyneuropathy and neuropsychiatric disease of critical care, many organizations focus on rehabilitation in critically ill patients' management. Despite the good outcomes from papers, there are debatable issues of method, safety and efficacy of rehabilitation. The investigators developed an early rehabilitation program (ERP) in our surgical ICU management and assessed safety and efficacy of it.

The ERP started in November 2014 in our 14-bed surgical ICU in Asan Medical Center. The investigators focused on early and 5-step rehabilitation program for patients who were admitted to SICU for at least 3 days. The investigators enrolled 69 patients (pre-ERP group) for 6 months before November 2014 and 62 patients (post-ERP group) for 6 months 1 year after the ERP started. The main measures were safety issues, delirium days, 28-d ventilator free-days, 28-d ICU free-days, hospital length of stay (LOS), ICU mortality, in-hospital mortality and 1 year mortality.

Study Type

Interventional

Enrollment (Actual)

131

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • patients who were admitted in SICU for at least 3 days

Exclusion Criteria:

  • readmission to SICU within current hospitalization open abdomen wound patients major bone fracture patients brain death patients active bleeding patients increased intra-cranial pressure patients paraplegic patients patients or their guardians did not agree with the ERP doctor's decision (Deconditioning patients, Procedure)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: pre-ERP
A group of the surgical ICU patients who had standard care before Asan medical center developed an early rehabilitation program (ERP)
Experimental: post-ERP
A group of the surgical ICU patients who had an early rehabilitation program (ERP) within SICU care
The investigators evaluated patients who were admitted SICU for more than 3 days for an early rehabilitation program and delivered one of 5-stepped rehabilitation program if the patient was eligible.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
28-day Ventilator-free days (days)
Time Frame: up to 28-day
Patients who died during the study were assigned scores of 0 for 28-day ventilator-free days.
up to 28-day
28-day ICU-free days (days)
Time Frame: up to 28-day
Patients who died during the study were assigned scores of 0 for 28-day ICU-free days
up to 28-day

Secondary Outcome Measures

Outcome Measure
Time Frame
Time to start rehabilitation from ICU admission (days)
Time Frame: up to 2 weeks
up to 2 weeks
ICU delirium days (days)
Time Frame: up to 4 weeks
up to 4 weeks
Total rehabilitation days within ICU days (days)
Time Frame: up to 4 weeks
up to 4 weeks
ICU readmission rate (%)
Time Frame: up to 24 weeks
up to 24 weeks
ICU mortality rate (%)
Time Frame: up to 24 weeks
up to 24 weeks
in-hospital mortality rate (%)
Time Frame: up to 24 weeks
up to 24 weeks
1 year mortality rate (%)
Time Frame: 1 year follow up from ICU admission
1 year follow up from ICU admission

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Suk-kyung Hong, Ph.D., Asan Medical Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2014

Primary Completion (Actual)

March 1, 2016

Study Completion (Actual)

March 1, 2016

Study Registration Dates

First Submitted

January 15, 2017

First Submitted That Met QC Criteria

February 14, 2017

First Posted (Actual)

February 16, 2017

Study Record Updates

Last Update Posted (Actual)

February 16, 2017

Last Update Submitted That Met QC Criteria

February 14, 2017

Last Verified

February 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • AsanMC-ERP

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on ICU-acquired Weakness

Clinical Trials on Early rehabilitation program

3
Subscribe